Polycythemia in a Pediatric Patient with Chronic Kidney Disease: Overuse of Erythropoerin During COVID-19 Isolation

dc.contributor.authorKandur, Yaşar
dc.contributor.authorAlpcan, Ayşegül
dc.contributor.authorYozgat, Mehmet
dc.contributor.authorTursun, Serkan
dc.date.accessioned2025-01-21T16:43:29Z
dc.date.available2025-01-21T16:43:29Z
dc.date.issued2021
dc.departmentKırıkkale Üniversitesi
dc.description.abstract[Abstract No tAvailable]
dc.identifier.endpage3398
dc.identifier.issn0931-041X
dc.identifier.issn1432-198X
dc.identifier.issue10
dc.identifier.startpage3398
dc.identifier.urihttps://hdl.handle.net/20.500.12587/25280
dc.identifier.volume36
dc.identifier.wosWOS:000696562600357
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofPediatric Nephrology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.titlePolycythemia in a Pediatric Patient with Chronic Kidney Disease: Overuse of Erythropoerin During COVID-19 Isolation
dc.typeConference Object

Dosyalar